Investor List:

Top Diagnostics Seed Investors (398)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Seth Bannon, Partner at Fifty Years
Seth Bannon
Fifty Years·Partner
Sweet spot: $1M
Range: $400K - $1.5M
Investors in San Francisco (CA)
Investors in Impact (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Impact (Pre-seed), Investors in AgTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Chemicals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Chemicals (Pre-seed), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Chemicals (Seed), Investors in Chemicals (Seed), Investors in DeepTech (Seed), Investors in AgTech (Seed), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Food and Beverage (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in AgTech (Seed), Investors in Impact (Seed), Investors in Impact (Seed), Investors in Food and Beverage (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Manufacturing (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Manufacturing (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Alexander Hall-Daniels, Associate at IndieBio
Alexander Hall-Daniels
IndieBio·Associate
Sweet spot: $525K
Range: $275K - $525K
Investors in United States, Investors in New York
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Robotics (Pre-seed), Investors in Hardware (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Health & Hospital Services (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Hardware (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Mehdi Maghsoodnia, Managing Partner at Combustion Ventures
Mehdi Maghsoodnia
Combustion Ventures·Managing Partner
Sweet spot: $50K
Range: $25K - $1M
Investors in SF Bay Area (CA)
Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Data Services (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Developer Tools (Pre-seed), Investors in Cloud Infrastructure (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Data Services (Pre-seed), Investors in Analytics (Pre-seed), Investors in Developer Tools (Pre-seed), Investors in BioTech (Pre-seed), Investors in Cloud Infrastructure (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Internet (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Analytics (Seed), Investors in Consumer Health (Seed), Investors in Data Services (Seed), Investors in Developer Tools (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Analytics (Seed), Investors in Developer Tools (Seed), Investors in Health IT (Seed), Investors in Data Services (Seed), Investors in Cloud Infrastructure (Seed), Investors in BioTech (Seed), Investors in Cloud Infrastructure (Seed), Investors in AI (Seed), Investors in Health IT (Seed), Investors in Consumer Internet (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Michael Sidler, General Partner at Redalpine Venture Partners
Michael Sidler
Sweet spot: $2.5M
Range: $500K - $5.0M
Investors in Europe, Investors in Germany
Photo of Jason G., Investor at B Capital Group
Jason G.
B Capital Group·Investor
Sweet spot: $25.0M
Range: $25.0M - $60.0M
Investors in SF Bay Area (CA)
Photo of Ling Wong, Managing Partner at Highbury Group
Ling Wong
Highbury Group·Managing Partner
Sweet spot: $10.0M
Range: $500K - $50.0M
Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Generative Tech/AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Seed), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in Generative Tech/AI (Series A), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Health IT (Series B), Investors in Diagnostics (Series B), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series B), Investors in Pharmaceuticals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in AI (Series B), Investors in Seattle / Portland (Other Lists), Investors in Investors who were founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox
Firms investing in this space